-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
- Centessa Pharmaceuticals plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.45M, a 11.8% increase year-over-year.
- Centessa Pharmaceuticals plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $32.6M, a 14.2% increase year-over-year.
- Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2023 was $29.4M, a 17.7% increase from 2022.
- Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2022 was $25M, a 68.1% increase from 2021.
- Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2021 was $14.9M, a 4320% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)